The DOI matches its Crossref record.
Biofunctionalized Phospholipid-Capped Mesoporous Silica Nanoshuttles for Targeted Drug Delivery: Improved Water Suspensibility and Decreased Nonspecific Protein Binding
Abstract
A main challenge in nanobiomedicine is the engineering of nanostructures or nanomaterials that can efficiently encapsulate drugs at high load, cross cell membranes, and controllably release their cargo at target sites. Although mesoporous silica nanoparticles (MSNs) are safe, versatile, and promising carrier materials for targeted drug delivery, their aggregation phenomena under physiological conditions (or salt-containing environments) and their nonspecific binding in protein-containing solutions (or serum) limit their applications in biological science and biomedicine. To address this challenge, we have developed a novel delivery system, termed a nanoshuttle, comprising a nanoscale PEGylated-phospholipid coating and 13-(chlorodimethylsilylmethyl)heptacosane-derivatized MSNs, in which therapeutic or imaging agents may be trapped and ligand-assisted targeted delivery may be achieved through surface functionalization of the phospholipids. As a proof of concept in this study, we selected fluorescein isothiocyanate and folate as the imaging tracer and targeted ligand, respectively. Relative to the bare MSNs, the lipid-capped MSNs exhibited superior suspensibility in phosphate-buffered saline and much lower nonspecific binding in vitro. Furthermore, enhanced specific cellular uptake by Hela cells occurred after administering the folate-sensitized phospholipid-capped MSNs. Our results suggest that these highly versatile multifunctional MSNs are promising vectors for nanomedicine applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Functionalized mesoporous silica materials for controlled drug delivery
Yang, P., Gai, S., & Lin, J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15308d · Cited by 1,399
Zhang, Z., Wang, L., Wang, J., Jiang, X., Li, X., Hu, Z., Ji, Y., Wu, X., & Chen, C. (2012) · Advanced Materials · doi:10.1002/adma.201104714 · Cited by 974
Self-citationMultifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
Argyo, C., Weiss, V., Bräuchle, C., & Bein, T. (2014) · Chemistry of Materials · doi:10.1021/cm402592t · Cited by 903
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
He, Q., & Shi, J. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm03851b · Cited by 691
Application of zirconium MOFs in drug delivery and biomedicine
Abánades Lázaro, I., & Forgan, R. S. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.09.009 · Cited by 678
Functionalization of Inorganic Nanoparticles for Bioimaging Applications
Erathodiyil, N., & Ying, J. Y. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000327 · Cited by 622
Porous Nanosized Particles: Preparation, Properties, and Applications
Valtchev, V., & Tosheva, L. (2013) · Chemical Reviews · doi:10.1021/cr300439k · Cited by 609
Zhao, Y., Sun, X., Zhang, G., Trewyn, B. G., Slowing, I. I., & Lin, V. S.-Y. (2011) · ACS Nano · doi:10.1021/nn103077k · Cited by 572
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Vallet-Regí, M., Colilla, M., Izquierdo-Barba, I., & Manzano, M. (2017) · Molecules · doi:10.3390/molecules23010047 · Cited by 538
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
He, Q., & Shi, J. (2014) · Advanced Materials · doi:10.1002/adma.201303123 · Cited by 482
Ahmad, F., Salem-Bekhit, M. M., Khan, F., Alshehri, S., Khan, A., Ghoneim, M. M., Wu, H.-F., Taha, E. I., & Elbagory, I. (2022) · Nanomaterials · doi:10.3390/nano12081333 · Cited by 356
Gao, L., Fei, J., Zhao, J., Li, H., Cui, Y., & Li, J. (2012) · ACS Nano · doi:10.1021/nn302634m · Cited by 332
Li, Z., Zhang, Y., & Feng, N. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1575806 · Cited by 321
Biosafety and Bioapplication of Nanomaterials by Designing Protein–Nanoparticle Interactions
Yang, S., Liu, Y., Wang, Y., & Cao, A. (2013) · Small · doi:10.1002/smll.201201492 · Cited by 296
Arcos, D., & Vallet-Regí, M. (2013) · Acta Materialia · doi:10.1016/j.actamat.2012.10.039 · Cited by 282
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet-Regí, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 270
Cauda, V., Argyo, C., & Bein, T. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm01390k · Cited by 254
Durfee, P. N., Lin, Y.-S., Dunphy, D. R., Muñiz, A. J., Butler, K. S., Humphrey, K. R., Lokke, A. J., Agola, J. O., Chou, S. S., Chen, I.-M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02819 · Cited by 219
Sun, Q., You, Q., Wang, J., Liu, L., Wang, Y., Song, Y., Cheng, Y., Wang, S., Tan, F., & Li, N. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b13651 · Cited by 109
Development of Mesoporous Silica Nanomaterials As a Vehicle for Anticancer Drug Delivery
Yanes, R. E., & Tamanoi, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.9 · Cited by 68
Antifouling zwitterionic pSBMA‐MSN particles for biomedical applications
Beltrán‐Osuna, Á. A., Ródenas‐Rochina, J., Gómez Ribelles, J. L., & Perilla, J. E. (2019) · Polymers for Advanced Technologies · doi:10.1002/pat.4505 · Cited by 14
Metadata
- Authors
- Wang, L.-S., Wu, L.-C., Lu, S.-Y., Chang, L.-L., Teng, I.-T., Yang, C.-M., & Ho, J.-A. A.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-07-12
- Volume
- 4
- Issue
- 8
- Pages
- 4371-4379
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2024638097
- Cited by
- 248
- References
- 0
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.